Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.419, 2003-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Prevalence of CYP2D6-metabolised drug use varies
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 527, 2007-01 ,pp. :
Access to resources
Recommend
Influence of CYP2D6 Genetics on Opioid Kinetics, Metabolism and Response
Current Pharmacogenomics, Vol. 3, Iss. 1, 2005-03 ,pp. :
Concurrent use of celecoxib and CYP2D6 substrates common
Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. :
Use of CYP2D6 genotyping in practice: tamoxifen dose adjustment
By Walko Christine M McLeod Howard
Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. :